OPTINOSE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 USD | +0.93% |
|
-2.70% | -16.28% |
| 20/05 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
| 14/05 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTINOSE, INC. | Other Pharmaceuticals | +0.93% | -2.70% | -16.28% | -13.60% | -85.77% | 156M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- OPTN Stock
- Charts OptiNose, Inc.
- Comparison Chart
